This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
USE OF inactivated poliomeylitis vaccine (IPV) in childhood immunization programs is still in the future. At the same time, eventual use is not ruled out.
At a late June meeting of the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention (CDC), members spent many hours discussing when and how to incorporate IPV into childhood immunization programs.
After agreeing to move ahead with incorporating it into the schedule of childhood immunization, the committee reversed itself. It finally decided unanimously to form a working group to explore the various policy options and develop a plan for eventually implementing the use of IPV. The plan is to be presented at the ACIP meeting in October.
The discussions about IPV took place in light of the fact that eight to 10 cases of paralytic polio occur in the United States each year because of the use of live
Marwick C. ACIP Delays Changing Polio Vaccine Advice. JAMA. 1995;274(3):203. doi:10.1001/jama.1995.03530030025009